Long term potential is huge, but PAB has always failed to re-rate and stabilize at the SP highs without any news of partnering or combination trials with major pharma or human trials. My prediction is that will come at some point in 2019.
Honestly it does not phase me to see the SP drop as I know one day we will be 20cents+ and just means more people have the opportunity to get on board the PAB rocket. Might even grab some more shares on the dips if my better half lets me.
PAB Price at posting:
5.1¢ Sentiment: Hold Disclosure: Held
